ClearPoint Neuro Inc (CLPT)
6.51
+0.11
(+1.72%)
USD |
NASDAQ |
May 20, 09:45
ClearPoint Neuro SG&A Expense (Quarterly): 6.131M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.131M |
December 31, 2023 | 6.067M |
September 30, 2023 | 5.741M |
June 30, 2023 | 6.652M |
March 31, 2023 | 5.891M |
December 31, 2022 | 4.908M |
September 30, 2022 | 4.82M |
June 30, 2022 | 5.048M |
March 31, 2022 | 4.194M |
December 31, 2021 | 4.093M |
September 30, 2021 | 4.244M |
June 30, 2021 | 3.572M |
March 31, 2021 | 3.232M |
December 31, 2020 | 2.996M |
September 30, 2020 | 2.745M |
June 30, 2020 | 2.339M |
March 31, 2020 | 2.575M |
December 31, 2019 | 2.821M |
September 30, 2019 | 2.093M |
June 30, 2019 | 2.171M |
March 31, 2019 | 1.974M |
December 31, 2018 | 2.085M |
September 30, 2018 | 1.843M |
June 30, 2018 | 2.015M |
March 31, 2018 | 1.915M |
Date | Value |
---|---|
December 31, 2017 | 2.271M |
September 30, 2017 | 1.766M |
June 30, 2017 | 1.916M |
March 31, 2017 | 2.050M |
December 31, 2016 | 2.219M |
September 30, 2016 | 1.886M |
June 30, 2016 | 1.888M |
March 31, 2016 | 1.974M |
December 31, 2015 | 1.762M |
September 30, 2015 | 2.133M |
June 30, 2015 | 2.187M |
March 31, 2015 | 2.289M |
December 31, 2014 | 2.247M |
September 30, 2014 | 2.062M |
June 30, 2014 | 1.929M |
March 31, 2014 | 1.801M |
December 31, 2013 | 2.027M |
September 30, 2013 | 1.698M |
June 30, 2013 | 1.703M |
March 31, 2013 | 1.633M |
December 31, 2012 | 1.445M |
September 30, 2012 | 1.442M |
June 30, 2012 | 1.803M |
March 31, 2012 | 1.340M |
December 31, 2011 | 1.123M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
2.093M
Minimum
Sep 2019
6.652M
Maximum
Jun 2023
4.117M
Average
4.144M
Median
SG&A Expense (Quarterly) Benchmarks
icad Inc | 3.984M |
Perspective Therapeutics Inc | 5.878M |
Xtant Medical Holdings Inc | 20.24M |
Asensus Surgical Inc | 8.016M |
Catheter Precision Inc | 2.656M |